Rewriting Life Software Predicts Cognitive Decline Using Brain Images Spotting people most at risk of developing Alzheimer’s is a difficult task. Now a neural network can identify those likely to be diagnosed in the next three years. by Emerging Technology from the arXiv 2017-04-28T11:02:00-04:00
Rewriting Life Amyloid-Busting Drugs for Alzheimer’s Keep Failing, but So Does Everything Else Drug failures may be telling us that we don’t know what causes Alzheimer’s disease. by Emily Mullin 2017-03-01T15:27:00-05:00
MIT News feature Tracing a Memory Susumu Tonegawa is finding out how the brain stores and retrieves individual memories. by Courtney Humphries, SM ’04 2016-10-18T00:00:00-04:00
Rewriting Life The Rogue Immune Cells That Wreck the Brain Beth Stevens thinks she has solved a mystery behind brain disorders such as Alzheimer’s and schizophrenia. by Adam Piore 2016-04-04T00:00:00-04:00
Rewriting Life To Treat Alzheimer’s, Drugmakers Embrace Early Intervention, Imaging Tests New antibody drugs show promise in slowing the advance of Alzheimer’s disease. by Antonio Regalado 2015-07-22T15:19:00-04:00
Rewriting Life Tiny Brain Clumps Offer New Clues into the Cause of Autism Brain “organoids” made from the stem cells of autism patients could help researchers determine the factors that lead to the disorder. by Mike Orcutt 2015-07-16T12:00:00-04:00
Rewriting Life Brain Organoids A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders. by Russ Juskalian 2015-02-18T00:05:00-05:00
Rewriting Life Alzheimer’s Ahead An epidemic of age-related dementia looms by Gary Small 2012-10-24T00:00:00-04:00
Rewriting Life The Dementia Plague As the world’s population of older people rapidly grows in the coming years, Alzheimer’s and other forms of dementia will become a health-care disaster. by Stephen S. Hall 2012-10-05T00:00:00-04:00
Rewriting Life A New Setback for Alzheimer's Drugs A compound that attacks amyloid plaques fails to help patients, raising questions about similar therapeutics. by Susan Young Rojahn 2012-08-09T00:00:00-04:00
